Bertrand Lioger

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

S. Le Burel, Stéphane Champiat, Christine Mateus et al. · European Journal of Cancer · 2017 · 196 citations

Inflammation, Autoimmune Disease, Immunotoxicology +7

Characteristics and Management of IgA Vasculitis (Henoch‐Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey

Alexandra Audemard‐Verger, Benjamin Terrier, Agnès Dechartres et al. · Arthritis & Rheumatology · 2017 · 152 citations · Full text

Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients

A. Mékinian, Matthieu Resche‐Rigon, Cloé Comarmond et al. · Journal of Autoimmunity · 2018 · 81 citations · Full text

Rheumatology, Vasculitis, Takayasu Arteritis +3

Efficacy and safety of rituximab for systemic lupus erythematosus‐associated immune cytopenias: A multicenter retrospective cohort study of 71 adults

Alexandra Serris, Zahir Amoura, Florence Canouï‐Poitrine et al. · American Journal of Hematology · 2017 · 80 citations · Full text

Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review

Éric Grignano, A. Mékinian, Thorsten Braun et al. · Leukemia Research · 2016 · 60 citations · Full text

Hematological Malignancy, Chronic Myelomonocytic Leukemia, Autoimmune Disease +15